For 45-year-old Marcus Wendling, who toughed out a half Ironman challenge, a diagnosis of stage 3 rectal cancer came out as a ...

Marcus Wendling toughed out a half Ironman — a grueling triathlon consisting of a 1.2-mile swim, a 56-mile bike ride and a 13 ...

A fit and healthy man has opened up about shockingly being diagnosed with rectal cancer after spotting one symptom, as he ...

Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

The surgical treatment of mid-low rectal cancer poses greater technical challenges, and whether robotic surgery provides superior safety and efficacy compared to laparoscopic surgery remains ...

Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair-deficient (dMMR) tumors, ...

PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers, according to results presented by Andrea Cercek, MD, at the AACR Annual ...

Among patients with mismatch repair–deficient (dMMR), locally advanced rectal cancer, neoadjuvant checkpoint ... those with residual disease were to undergo resection. In this analysis, the ...